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ABSTRACT 
 
Introduction: Preclinical studies have reported that Murraya koenigii leaves (MKL) could enhance 
memory. MKL is also known for its antioxidant activity. The current study was to assess the possible 
neuroprotective potential of MKL methanolic extract in a two vessel occlusion (2VO) rat model of partial 
global cerebral ischaemia. Methods: Rats were divided into memory and learning groups. Each group was 
subdivided into sham control, untreated 2VO and MKL-treated 2VO subgroups. The Morris water maze test 
was implemented to assess the rats’ cognitive function postoperatively. Brain samples were 
histopathologically examined for viable neurons within the CA1 hippocampal region. Results: Water maze 
test findings showed that MKL positively improved memory and learning impairments. However, this 
improvement in memory test for the treated group was still significantly inferior to that of the healthy 
control group. Additionally, MKL treated group exhibited insignificant difference in the number of viable 
hippocampal CA1 pyramidal neurons from that of the untreated 2VO group, whereas both MKL treated and 
untreated 2VO groups showed significantly less viable neurons when compared with the control group. 
Conclusion: MKL extract modestly improved memory without providing substantial neuroprotective 
action to the hippocampal neurons in rats with chronic partial global cerebral ischaemia.   
 
KEYWORDS: Murraya Koenigii, Spatial memory, Neuroprotection, Cerebral hypoperfusion, 
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INTRODUCTION 
 
Murraya Koenigii leaves (MKL), belonging to the 
plant family “Rutaceae”, generally known as curry 
patta, is a popular Indian food spice and a well-
known Ayurvedic medicinal plant. Traditionally, MKL 
is utilized to treat vomiting, diarrhoea and also used 
as a general tonic or an energy boosting agent.1 
Evidence based reports within the last decade 
highlighted its robust antioxidant,2 and reactive 
nitrogen species scavenging activities.3 These 
potentially beneficial mechanisms were attributed to 
some carbazole alkaloids that were identified as 
predominant active ingredients of MKL. 4 
 
Recently, two important studies on experimental 
animals with drug induced amnesia asserted that 
MKL and its ethanolic extract could significantly 
enhance memory and prevent scopolamine triggered 
memory impairment. Both studies have related          
this mnemonic activity to acetylcholine release 
stimulation and/or anticholinesterase mechanism of 
MKL action with a final recommendation for future 
research to test the neuroprotective effects of the 
MKL extract on a more scientific animal model of 
Alzheimer’s disease (AD).5,6 Permanent two vessel 
occlusion (2VO) surgery is now broadly employed to 
induce hippocampal neurodegeneration as a result of 
global long standing cerebrovascular hypoperfusion.  
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The resultant hippocampal neuronal cell loss in 2VO 
rats is said to be closely resembling that of AD both 
in its origin and outcome. As for its origin, it is now 
widely accepted that sporadic AD may result from 
one or more vascular risk factors that lead to chronic 
cerebral hypoperfusion which in turn would impede 
the transport of essential nutrients to the brain. 8 
Concerning their outcomes, both AD patients                
and 2VO rats were found to suffer progressive      
spatial memory decline as an early manifestation               
of hippocampal neurodegeneration.9 Moreover, 
oxidative stress and neuroinflammation are thought 
to play a pivotal role in AD pathogenesis10 as well            
as in 2VO induced neurodegeneration in rats.11 Since 
the CA1 hippocampal region was reported to be the 
most sensitive area for neurodegeneration following 
2VO intervention, 12 the current study was designed 
to assess the potential neuroprotective effects of 
the MKL extract on chronically hypoperfused rat’s 
brain that resulted from 2VO intervention. The 
assessment was based on learning and memory test 
protocols, using the Morris water maze (MWM) 
apparatus, and histopathological examination of 
hippocampal sections.  
 
METHODS 
 
MKL extraction 
 
Fresh curry leaves (10kg) were harvested from 
Pandan River Forest, a few kilometres away from 
Kuantan. MKL was identified and authenticated by a 
taxonomist in the Faculty of Pharmacy, IIUM. 
Voucher specimen was deposited at the Faculty’s 
herbarium. The leaves were left to dry before they 
were gounded to powder and dissolved in methanol 
under magnetic stirrer for 24 hours. The pure 
extract was separated on the next day using Rotary 
Evaporator apparatus. The total yield of MKL extract 
was 200 grams.   
 
Animal groups 
 
Sixty male Sprague Dawley rats were purchased from 
the Faculty of Veterinary Medicine, University Putra 
Malaysia. The rats’ weights range was 250-350 grams 
on the date of surgery. Animals had free access to 
water and food pellets throughout the study and           
an equal daily exposure to light and darkness.                
Rats were treated according to the guidelines 
for the care and use of mammals in neuroscience     
and  behavioural  research as well as the 
recommendations of the IIUM ethical committee.  
After an acclimatization period of 7 days, animals 
were randomly and equally divided into 3 main 
groups: Goup A (vehicle treated and sham operated), 
labelled as sham. Group B (vehicle treated and 2VO 
operated), labelled as 2VO. Group C (MKL+vehicle 
treated and 2VO operated), labelled as MKL.  
 
The daily oral dose of MKL (50 mg/kg) was 
commenced 10 days before the date of 2VO surgery 
and continued until the end of the 10th postoperative 
week (day70) as shown in Fig.1. 
 
Each one of the main groups was further subdivided 
into 2 subgroups. Long-term memory (LTM) 
subgroups and short-term memory + working memory 
(STM+WM) subgroups (Figure1A).  
 
2VO surgery 
 
Under combined intraperitoneal general anaesthesia 
consisting of ketamine (90 mg/kg) and xylazine 
(10mg/kg), the common carotid arteries were 
bilaterally exposed, separated from the vagus nerve, 
permanently double ligated with a silk suture and 
cut in between the two ligatures. Rats were kept 
under a heating lamp until full recovery from 
anaesthesia. Postoperative buprenorphine was given 
intramuscularly to selected animals which developed 
signs of distress or pain.   
 
MWM apparatus 
 
A black fibre glass circular tank, 2 meter in 
diameter, was used for evaluating LTM, STM and 
working memory (WM). A black platform, 10 cm in 
diameter, was submerged below the water 
throughout all test protocols, except during 
habituation training before the first test day and 
during the single cued version trial at the end of the 
last test trial.  
 
In LTM test protocol, the animals were trained on 
the swimming Task before undergoing 2VO surgery. 
The position of the platform remained fixed (in the 
left lower quadrant) for 3 consecutive days with 4 
trials per day with a different starting point of each 
trial. The maximum duration of time allowed for 
each animal during a trial was 120 seconds. 
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Figure 1. (A): Experimental protocols for the study groups. LTM= Long-term memory, STM= short-term memory, WMT= 
working memory test. (B1& B2): LTM acquisition trials depicting improved daily performance of all groups in (B1) escape 
latency (B2) pathlength without any significant differences among groups. (C1& C2): LTM test depicting significantly 
shorter results of the sham group as compared to 2VO and MKL groups in (C1) escape latency (C2) pathlength. **p < 0.01 
as compared to 2VO, ## p < 0.01 as compared to sham. 
Animals which failed to locate the platform within 
the 120 seconds were gently guided to the platform 
and left there for 30 seconds, so as to learn its 
position in relation to the extra-maze visual cues 
(coloured posters pasted to the lab walls). 
Parameters recorded for each animal by Anymaze 
video tracking software (Stoelting Co., USA) were 
escape latency time, path-length and swimming 
speed. At the tenth week post 2VO all animals of 
LTM group were subjected again to a single day test 
consisting of 4 trials. This was followed on the next 
day by retention probe single trial memory test for 
60 seconds with the platform removed from the pool. 
During the probe test, the parameters recorded were 
the time spent by each animal in the target (left 
lower) zone and the total number of annulus 
crossings. 
 
In STM test protocol the animals were subjected for 
the first time to MWM on the 10th postoperative week 
(no preoperative training). The test protocol was for 
4 consecutive days followed on the fifth day of the 
retention probe memory test with similar parameters 
recorded as those with LTM protocol where the 
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platform was constantly hidden below the water 
surface in the same left lower quadrant. WMT was 
conducted for 3 successive days after the last probe 
memory test for STM subgroups. In WMT protocol the 
platform’s location was changed on a daily basis 
among the right upper, right lower and left upper 
quadrants of the pool as described in table 1. 
Parameters recorded were the escape latency time, 
total pathlength until reaching the platform and 
swimming speed.  
 
Table 1: MWM protocols for LTM, STM and WM 
subgroups. 
Histopathology 
 
At the end of the tenth postoperative week all 
animals were humanely euthanized using an overdose 
of inhaled diethyl ether. The brains were rapidly 
collected to be fixed in 10% formaldehyde for 72 hrs. 
Coronal hippocampal sections were prepared from 
the right and the left hemispheres to be stained with 
cresyl violet and FJC stains, respectively. Staining 
procedures were similar to those described by 
previous studies.7,13 Slides were examined by a 
histopathologist who was blinded to the study 
groups. Calculation of viable pyramidal neurons 
within 1mm2 of the CA1 hippocampal subfield was 
performed according to the method described 
previously by Azzubaidi and co-workers.14 
 
Statistical analysis 
 
Anymaze software analysed differences in mean 
values of escape latencies, pathlengths and 
swimming speeds using two way ANOVA with one 
repeated measure (both factors fixed). Data from 
retention probe memory tests and the mean viable 
neurons of the study groups were subjected to a one 
way ANOVA with post hoc Tukey’s test for groups’ 
comparisons using SPSS software version 17.0. 
Results were expressed as mean (SEM). p values less 
than 0.05 were considered statistically significant. 
 
 LTM STM 
WMT 
(learning) 
Preoperative MWM 
training 
Yes No No 
Acquisition trials Yes Yes No 
Daily alteration of 
platform position 
inside the pool 
No No Yes 
Retention probe 
memory test 
Yes Yes No 
RESULTS  
 
Preoperative acquisition trials 
No significant differences among groups were 
observed during the pre 2VO acquisition trials of LTM 
test, neither in escape latency [F(2,117) = 0.88, p = 
0.41] (Figure1 B1) nor in the pathlengths until 
reaching the platform [F(2,117) = 2.85,  p = 0.06] 
(Figure1 B2). 
 
Postoperative Mortality and Blindness rates 
 
Table 2 illustrates post 2VO mortality and blindness 
rates. Blind rats were excluded from the MWM test 
as it requires satisfactory vision for the animal to 
build its spatial memory. 
 
Table 2: Postoperative mortality and blindness 
rates among study groups. 
**p < 0.01 versus sham group. 
 
LTM results 
 
Escape latency results of the tenth postoperative 
week showed significantly shorter time required by 
the sham group in comparison with the other 2 
groups [F (3,35) = 30.43, p <0.01]. The escape 
latency time of MKL group also was significantly 
shorter than that of 2VO group (p <0.01) (Figure1 
C1). Whereas the pathlength results showed that the 
difference was significant only when comparing 
sham with the other 2 groups [F (3,35) = 18.12,p 
<0.01]. That is to say, the total distance travelled by 
MKL and 2VO were not statistically significant (p = 
0.06) (Figure1 C2). 
 
Retention probe LTM results 
 
The sham group demonstrated significantly longer 
time in the target zone of the maze than 2VO and 
MKL groups [F (3,33) = 9.14, p < 0.01].However, 
difference between 2VO and MKL groups was not 
significant (p = 0.10) (Figure 2 A1). In comparing the 
number of annulus crossings among all groups no 
significant difference was found [F (3,33) = 2.33, p = 
0.09] (Figure 2 A2).  
Postoperative rates sham 2VO MKL 
Mortality  (0%)  (42.10%)**  (30%)** 
Blindness (0%) (9%)  (5%) 
Total operated 20 38 30 
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STM Acquisition results 
 
Both sham and MKL groups showed significantly 
shorter escape latency time [F (2,27) = 34.49, p < 
0.01] (Figure 2 B1) and pathlengths travelled [F 
(3,36) = 3.91, p = 0.01] (Figure 2 B2) than that of 
VO group. Nevertheless, the difference was found 
to be significant between sham and MKL groups in 
both parameters.  
 
Retention probe STM results 
 
The sham group demonstrated significantly longer 
time spent in the target zone of the maze [F(3,36) 
= 20.79, p < 0.01] than 2VO and MKL groups. Yet, 
MKL group also showed significantly longer duration 
(p < 0.01) as compared to 2VO group (Figure 2 C1). 
Sham group also showed a significantly higher 
number of annulus crossings than both 2VO and 
MKL groups [F (3,36) = 6.56, p < 0.01], while the 
difference between 2VO and MKL groups was not 
significant (p = 0.29) (Figure 2 C2).   
 
WMT results 
 
There were significant differences among all 
groups, both in escape latency [F (3,36) = 38.11, p 
< 0.01] and pathlength [F (3,36) = 37.06, p < 0.01] on 
each of the 3 WMT days (Figure 3 A1 & A2).  
 
Swimming speed results 
 
Both LTM and (STM+WM) subgroups showed no 
significant differences in swimming speed during the 
last phase of the test [F (3,35) = 0.06, p = 0.9] and [F 
(2,27) = 0.07, p = 0.9], respectively (Figure 3 B1 & 
B2). 
 
Histopathology results 
 
A-FJC stain results 
Under a fluorescent microscope with FITC filter the 
three groups did not show any difference in their 
fluorescence intensity within CA1 pyramidal 
hippocampal layer (Figure 3 C1- C3).  
 
B-Cresyl violet stain 
1– Qualitative assessment 
Pyramidal neurons having regular boundaries, a light 
colored cytoplasm and a distinct nucleus were 
considered normal and counted as viable (Figure 4 
A), whereas shrunken cells that lost their 
characteristic triangular outlines with irregular cell 
membranes and darkly stained cytoplasm 
 
 
 
 
 
 
 
 
 
 
                                    
Figure 2. (A1 & A2): Retention probe LMT is depicting differences among groups in (A1) time spent in the target (left 
lower) zone (A2) number of annulus crossings. **P<0.01 as compared to the other 2 groups. (B1 & B2): STM result is       
depicted significantly shorter time (B1) and distance travelled (B2) for sham and MKL groups than those of 2VO group.          
**p<0.01 as compared to 2VO, ## p< 0.01 as compared to sham. (C1 & C2): Retention probe SMT is depicting differences 
among groups in (C1) time spent in the target (left lower) zone (C2) number of annulus crossings. **p <0.01 as compared 
to 2VO, ## p < 0.01 as compared to sham. 
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Figure 3. (A1&A2): WMT result is depicted significantly longer (A1) duration and (A2 ) distance travelled by 2VO and 
MKL groups as compared to the sham group. **p < 0.01 as compared to 2VO, ## p < 0.01 as compared to sham. (B1&B2): 
Swimming speed results from (B1) LTM test (B2) WMT depicting insignificant differences among tested groups. (C1, C2 
&C3): Light photomicrograph depicting CA1 pyramidal cells with no significant difference between study groups: sham 
(C1), 2VO (C2) and MKL (C3). Scale bar = 500 µm.  
medicinal plant. The permanent 2VO rat model is 
gaining more acceptance worldwide as a paradigm 
exemplifying the vascular hypothesis for AD, 16,17  
MKL extract was tested in this 2VO model with the 
aim of evaluating its expected neuroprotective 
properties before the neurodegenerative process 
takes place. For that reason MKL extract was 
administered 10 days prior to the date of inducing 
cerebrovascular hypoperfusion. This was of 
particular importance because of the general 
concept that the resulting neurodegeneration in AD 
as well as in 2VO rat model is irreversible though 
preventable. 16       
 
Significant early postoperative mortality rate may 
reflect a primary evidence that MKL pre-treatment 
could not protect the vital centers of the brain from 
the immediate diminishment in metabolic supplies 
which resulted from the sudden acute drop in 
cerebral blood flow. This postoperative mortality 
indistinguishable from the nucleus were considered 
degenerated and therefore not counted as viable in 
2VO treated rats (Figure 4 B). Treatment of 2VO rats 
with MKL (group C) showed normal pyramidal cells 
dominated treated rat hippocampal sections with  
clear and well defined nucleus (Figure 4 C). 
 
2– Quantitative assessment 
The mean viable CA1 pyramidal neurons were 
significantly higher (p < 0.01) in sham group than 
both 2VO and MKL groups. However, the difference 
was insignificant (p = 0.37) when comparing MKL 
with 2VO viable neuronal count (Figure 4 D). 
 
DISCUSSION 
 
The promising preliminary results of MKL extract as 
an antioxidant,2 and memory enhancing agent 5,15  
prompted researchers to conduct a more specific 
study to test the neuroprotective potential of this 
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Figure 4. Cresyl violet stained light photomicrographs depicting CA1 pyramidal neurons from sham group  (A), 2VO 
group (B), MKL group (C) and a quantitative comparison of the viable pyramidal neuron of the 3 study groups (D). Black 
arrows= viable pyramidal cells, yellow arrows= degenerated pyramidal cells. **p < 0.01 versus sham group.  
was found to be of a much lower rate in rats treated 
with other medicinal plant extracts, 18 which might 
indicate a lower efficacy of MKL neuroprotective 
potential. Significant impairment in the water maze 
performance of all untreated 2VO subgroups in LTM, 
STM and WM protocols 10 weeks post 2VO surgery as 
compared to the sham group denotes severe 
deterioration in these cognitive functions. This is in 
agreement with the results of other studies. 19- 21 
 
MKL treated group did not show a consistent 
performance throughout the MWM tests. The 
significantly shorter escape latency time of MKL 
treated than 2VO group was simultaneously 
significantly longer (worse) than that of the sham 
control group. Moreover, the comparable durations 
of time spent in the target zone for untreated 2VO 
and MKL treated groups that were both significantly 
shorter than the sham group during the retention 
probe memory test is another indication of MKL 
modest preventive action against LTM impairment 
induced by 2VO. This was somehow contrast to what 
was reported by other researchers who asserted a 
significant improvement in memory and learning for 
MKL treated group.5,6 The dissimilarity in our findings 
as compared to the aforementioned studies may be 
ascribed, on one hand, to differences for modelling 
memory impairment, and to the different procedures 
employed to assess memory and learning 
performances among tested groups on the other 
hand. While the  method adopted in the above 
studies to establish the memory impairment were 
drug induced amnesia and by using aged mice, 2VO    
is considered a more specific model for 
neurodegeneration giving a clearer picture about the 
expected neuroprotection of the tested agent. 
Additionally, the chronic nature of our study 
(animals tested 10 weeks postoperatively) may 
provide a better and more accurate assessment of 
the probable neuroprotection and memory 
enhancement than in other shorter studies. The 
chronicity of the designed study is essential        
since the exhaustion of intracellular stores of 
neurotransmitters involved in memory and learning 
is time dependent. 22 As for the procedures used to 
evaluate memory performance, MWM test is 
considered superior to other tests, including radial 
arm and elevated plus mazes in assessing LTM, STM 
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and WM because of lower possibility of test biases, 
more reliable tendency to finish the swimming task 
by the rats and fewer chances of developing 
olfactory cues for MWM in comparison with other 
behavioural tests.23 Absence of significant swimming 
speed differences throughout LTM and WM tests 
(results not shown) reassured that the tested 
parameters were not confounded by differences in 
swimming speed. Since it has already been reported 
that MKL treatment inhibits cholinesterase enzyme 
and thereby increasing acetylcholine levels in the 
brain, 6 there is no doubt that the good water maze 
rats performances during STM and WM tests in 
comparison with the untreated group was due to 
sustainable quantities of neurotransmitters that 
were able to maintain the memory and learning 
faculty of the treated group at a significantly higher 
level than that of the untreated 2VO group. The 
question, however, remained of whether this 
significant difference was merely a result of 
acetylcholinesterase enzyme inhibition or due to 
tangible neuroprotective activity exerted by the 
carbazole alkaloid compounds of MKL which are 
thought to possess potent antioxidant actions. 15 
 
Quantitative comparison of viable pyramidal cell 
numbers among the three groups clearly showed 
that there was an insubstantial neuroprotective 
action from MKL treatment, at least within the CA1 
hippocampal subfield, as the mean viable neuronal 
cell count was significantly lower in the treated 
group than that of sham group. The negative 
findings of FJC stain was against our prediction since 
it is regarded as highly specific for detecting 
neurodegenerated cells and even axons under 
fluorescent microscope. 13 
 
Lack of high fluorescent intensity within the 
untreated 2VO group was in contrast to Ehara and 
Ewidi who to induce cerebral neurodegeneration by 
chemical intoxication of the brain and observed          
FJC-positive fibres, but little in cell bodies of             
the neurons in the substantia nigra of the male 
homozygous zitter mutant (zi/zi) rats. 24 
Nevertheless, our negative FJC findings in untreated 
2VO group stood in agreement with the observation 
of Ritchie et al.; who stained the  hippocampi of 
Sprague–Dawley rats with the same fluorescent stain 
6 weeks post 2VO and postulated that this negative 
finding may indicate that the neurodegenerative 
event might have happened at an earlier stage that 
rendered it impossible to be picked up by the 
fluorescent stain at the later stage; 25  it might be 
related to species differences. 
 
CONCLUSION 
 
Our study concludes that the memory enhancing 
activity achieved by MKL treatment cannot be 
attributed to a tangible neuroprotective action, but 
rather to increase acetylcholine levels in the brain 
secondary to acetylcholinesterase enzyme 
inhibition. 
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